@newgen consultancy Sir, price band upto 790 (against expectations of 630).
Can you point out what is unique in this company (in addition to a stationary company) that is inviting such high GMP. Am I missing something?Do you think GMP will sustain after declaration of price band? Don't you think GMP before price band decision was a way to get higher than genuine price band?
Till now, complete focus has been on GMP without going through its business, revenue, profit and other parameters. PAT in particular needs some consideration. It was in negative in FY21 & only 17 cr in FY22 and suddenly jumped to 100 cr in FY23 with borrowings also 100 cr.
Please provide some insight and your opinion after finalisation of price band.